Remi-Martin Laberge

Person

Novato, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treating liver disease by selectively eliminating senescent cells
- Patent number 11,980,616
- Issue date May 14, 2024
- Mayo Foundation for Medical Education and Research
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating cardiovascular disease by selectively eliminating senescen...
- Patent number 11,963,957
- Issue date Apr 23, 2024
- Mayo Foundation for Medical Education and Research
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treating cognitive decline and other neurodegenerative conditions b...
- Patent number 11,351,167
- Issue date Jun 7, 2022
- Buck Institute for Research on Aging
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptide-based proteasome inhibitors for treating conditions mediate...
- Patent number 10,689,416
- Issue date Jun 23, 2020
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid construct with a p16 promoter that causes a prodrug co...
- Patent number 10,655,144
- Issue date May 19, 2020
- Buck Institute for Research on Aging
- Marco Demaria
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Removing senescent cells from a mixed cell population or tissue usi...
- Patent number 10,517,866
- Issue date Dec 31, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptide-based proteasome inhibitors for treating conditions mediate...
- Patent number 10,519,197
- Issue date Dec 31, 2019
- UNITY BIOTECHNOLOGY, INC.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions of matter for treatment of ophthalmic conditions by se...
- Patent number 10,478,432
- Issue date Nov 19, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Unit dose of an aryl sulfonamide that is effective for treating eye...
- Patent number 10,478,433
- Issue date Nov 19, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for killing senescent cells and for treati...
- Patent number 10,413,542
- Issue date Sep 17, 2019
- Buck Institute for Research on Aging
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treating atherosclerosis by removing senescent foam cell macrophage...
- Patent number 10,328,058
- Issue date Jun 25, 2019
- Mayo Foundation for Medical Education and Research
- Darren J. Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalm...
- Patent number 10,328,073
- Issue date Jun 25, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating pulmonary conditions by selectively removing senescent cel...
- Patent number 10,258,618
- Issue date Apr 16, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of optimizing conditions for selectively removing a pluralit...
- Patent number 10,213,426
- Issue date Feb 26, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of joint pain
- Patent number 10,130,628
- Issue date Nov 20, 2018
- UNITY BIOTECHNOLOGY, INC.
- Nathaniel David
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of ophthalmic conditions by selectively removing senescen...
- Patent number 10,010,546
- Issue date Jul 3, 2018
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment for osteoarthritis in a joint by administering a means fo...
- Patent number 9,993,472
- Issue date Jun 12, 2018
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associat...
- Patent number 9,980,962
- Issue date May 29, 2018
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transgenic mouse having a transgene that converts a prodrug into a...
- Patent number 9,901,080
- Issue date Feb 27, 2018
- Buck Institute for Research on Aging
- Judith Campisi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transgenic mouse for determining the role of senescent cells in cancer
- Patent number 9,901,081
- Issue date Feb 27, 2018
- Buck Institute for Research on Aging
- Judith Campisi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibiting activity of senescent cells using a glucocorticoid
- Patent number 9,884,065
- Issue date Feb 6, 2018
- Buck Institute for Research on Aging
- Judith Campisi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment for osteoarthritis by intra-articular administration of a...
- Patent number 9,855,266
- Issue date Jan 2, 2018
- Unity Biotechnology, Inc.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Unit dose of a cis-imidazoline for treating an osteoarthritic joint...
- Patent number 9,849,128
- Issue date Dec 26, 2017
- Unity Biotechnology, Inc.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Methods of Treating Retinal Vasculopathies
- Publication number 20240245680
- Publication date Jul 25, 2024
- Unity Biotechnology, Inc.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MED...
- Publication number 20220096466
- Publication date Mar 31, 2022
- Buck Institute for Research and Aging
- Shankar J. Chinta
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATING CARDIOVASCULAR DISEASE BY SELECTIVELY ELIMINATING SENESCEN...
- Publication number 20210169875
- Publication date Jun 10, 2021
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING LIVER DISEASE BY SELECTIVELY ELIMINATING SENESCENT CELLS
- Publication number 20210169876
- Publication date Jun 10, 2021
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS B...
- Publication number 20210030752
- Publication date Feb 4, 2021
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways...
- Publication number 20200360386
- Publication date Nov 19, 2020
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...
- Publication number 20200354336
- Publication date Nov 12, 2020
- Unity Biotechnology, Inc.
- Nick Vlahakis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Remo...
- Publication number 20200338094
- Publication date Oct 29, 2020
- Unity Biotechnology, Inc.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF A HETEROCYCLIC BCL-2 INHIBITOR FOR REMOVING SENESCENT CELLS...
- Publication number 20200338097
- Publication date Oct 29, 2020
- Unity Biotechnology, Inc.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...
- Publication number 20200199103
- Publication date Jun 25, 2020
- Unity Biotechnology, Inc.
- Nick Vlahakis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS B...
- Publication number 20200030323
- Publication date Jan 30, 2020
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Peptide-based proteasome inhibitors for treating conditions mediate...
- Publication number 20200002378
- Publication date Jan 2, 2020
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPY FOR REMOVING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCI...
- Publication number 20190343832
- Publication date Nov 14, 2019
- Unity Biotechnology, Inc.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MED...
- Publication number 20190269675
- Publication date Sep 5, 2019
- Buck Institute for Research and Aging
- Shankar J. Chinta
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHEMICAL COMPOUNDS FOR TREATING ATHEROSCLEROSIS BY STABILIZING ATHE...
- Publication number 20190175623
- Publication date Jun 13, 2019
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SULFONAMIDE INHIBITORS OF BCL-2 AND BCL-XL TO TREAT OPHTHALM...
- Publication number 20190022090
- Publication date Jan 24, 2019
- Unity Biotechnology, Inc.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Pharmaceutical Products and Drug Combinations for Treating Atherosc...
- Publication number 20190000846
- Publication date Jan 3, 2019
- Mayo Foundation for Medical Education and Research
- Jan M.A. van Deursen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Unit Dose of an MDM2 Inhibitor that Provides Long-Lasting Relief fr...
- Publication number 20180303828
- Publication date Oct 25, 2018
- Unity Biotechnology, Inc.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Compositions for Killing Senescent Cells and for Treati...
- Publication number 20180256568
- Publication date Sep 13, 2018
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REMOVING SENESCENT CELLS FROM A MIXED CELL POPULATION OR TISSUE USI...
- Publication number 20180250296
- Publication date Sep 6, 2018
- Unity Biotechnology, Inc.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING PULMONARY CONDITIONS BY SELECTIVELY REMOVING SENESCENT CEL...
- Publication number 20180235956
- Publication date Aug 23, 2018
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Ophthalmic Conditions by Selectively Removing Senescen...
- Publication number 20180235957
- Publication date Aug 23, 2018
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING SENESCENCE-ASSOCIATED DISEASE...
- Publication number 20180193458
- Publication date Jul 12, 2018
- Unity Biotechnology, Inc.
- Jose Alberto Lopez-Dominguez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nucleic Acid Construct with a p16 Promoter that Causes a Prodrug Co...
- Publication number 20180139939
- Publication date May 24, 2018
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Marco Demaria
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
TREATMENT OF OPHTHALMIC CONDITIONS BY SELECTIVELY REMOVING SENESCEN...
- Publication number 20180117038
- Publication date May 3, 2018
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment for Idiopathic Pulmonary Fibrosis and Chronic Obstructive...
- Publication number 20180110787
- Publication date Apr 26, 2018
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Remo...
- Publication number 20180000816
- Publication date Jan 4, 2018
- Unity Biotechnology, Inc.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATI...
- Publication number 20170348307
- Publication date Dec 7, 2017
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Pain
- Publication number 20170326136
- Publication date Nov 16, 2017
- Unity Biotechnology, Inc.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF A HETEROCYCLIC BCL-2 INHIBITOR FOR REMOVING SENESCENT CELLS...
- Publication number 20170266211
- Publication date Sep 21, 2017
- Unity Biotechnology, Inc.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Remi-Martin Laberge

Person

Patents Grantslast 30 patents

Treating liver disease by selectively eliminating senescent cells

Treating cardiovascular disease by selectively eliminating senescen...

Treating cognitive decline and other neurodegenerative conditions b...

Peptide-based proteasome inhibitors for treating conditions mediate...

Nucleic acid construct with a p16 promoter that causes a prodrug co...

Removing senescent cells from a mixed cell population or tissue usi...

Peptide-based proteasome inhibitors for treating conditions mediate...

Compositions of matter for treatment of ophthalmic conditions by se...

Unit dose of an aryl sulfonamide that is effective for treating eye...

Methods and compositions for killing senescent cells and for treati...

Treating atherosclerosis by removing senescent foam cell macrophage...

Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalm...

Treating pulmonary conditions by selectively removing senescent cel...

Method of optimizing conditions for selectively removing a pluralit...

Treatment of joint pain

Treatment of ophthalmic conditions by selectively removing senescen...

Treatment for osteoarthritis in a joint by administering a means fo...

Use of sulfonamide inhibitors of Bcl-2 to treat senescence-associat...

Transgenic mouse having a transgene that converts a prodrug into a...

Transgenic mouse for determining the role of senescent cells in cancer

Inhibiting activity of senescent cells using a glucocorticoid

Treatment for osteoarthritis by intra-articular administration of a...

Unit dose of a cis-imidazoline for treating an osteoarthritic joint...

Patents Applicationslast 30 patents

Methods of Treating Retinal Vasculopathies

TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MED...

TREATING CARDIOVASCULAR DISEASE BY SELECTIVELY ELIMINATING SENESCEN...

TREATING LIVER DISEASE BY SELECTIVELY ELIMINATING SENESCENT CELLS

TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS B...

Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways...

Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...

Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Remo...

USE OF A HETEROCYCLIC BCL-2 INHIBITOR FOR REMOVING SENESCENT CELLS...

Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...

TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS B...

Peptide-based proteasome inhibitors for treating conditions mediate...

THERAPY FOR REMOVING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCI...

TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MED...

CHEMICAL COMPOUNDS FOR TREATING ATHEROSCLEROSIS BY STABILIZING ATHE...

USE OF SULFONAMIDE INHIBITORS OF BCL-2 AND BCL-XL TO TREAT OPHTHALM...

Pharmaceutical Products and Drug Combinations for Treating Atherosc...

Unit Dose of an MDM2 Inhibitor that Provides Long-Lasting Relief fr...

Methods and Compositions for Killing Senescent Cells and for Treati...

REMOVING SENESCENT CELLS FROM A MIXED CELL POPULATION OR TISSUE USI...

TREATING PULMONARY CONDITIONS BY SELECTIVELY REMOVING SENESCENT CEL...

Treatment of Ophthalmic Conditions by Selectively Removing Senescen...

COMPOSITIONS AND METHODS FOR TREATING SENESCENCE-ASSOCIATED DISEASE...

Nucleic Acid Construct with a p16 Promoter that Causes a Prodrug Co...

TREATMENT OF OPHTHALMIC CONDITIONS BY SELECTIVELY REMOVING SENESCEN...

Treatment for Idiopathic Pulmonary Fibrosis and Chronic Obstructive...

Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Remo...

METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATI...

Treatment of Pain

USE OF A HETEROCYCLIC BCL-2 INHIBITOR FOR REMOVING SENESCENT CELLS...